TENAX THERAPEUTICS INC (TENX) Fundamental Analysis & Valuation

NASDAQ:TENX • US88032L6056

Current stock price

14.45 USD
+0.97 (+7.2%)
At close:
14.45 USD
0 (0%)
After Hours:

This TENX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TENX Profitability Analysis

1.1 Basic Checks

  • In the past year TENX has reported negative net income.
  • TENX had a negative operating cash flow in the past year.
  • TENX had negative earnings in each of the past 5 years.
  • In the past 5 years TENX always reported negative operating cash flow.
TENX Yearly Net Income VS EBIT VS OCF VS FCFTENX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

  • The Return On Assets of TENX (-50.47%) is comparable to the rest of the industry.
  • TENX has a Return On Equity of -54.19%. This is in the better half of the industry: TENX outperforms 60.85% of its industry peers.
Industry RankSector Rank
ROA -50.47%
ROE -54.19%
ROIC N/A
ROA(3y)-44.89%
ROA(5y)-201.92%
ROE(3y)-56.18%
ROE(5y)-337.1%
ROIC(3y)N/A
ROIC(5y)N/A
TENX Yearly ROA, ROE, ROICTENX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

1.3 Margins

  • TENX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TENX Yearly Profit, Operating, Gross MarginsTENX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. TENX Health Analysis

2.1 Basic Checks

  • TENX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for TENX has been increased compared to 5 years ago.
  • There is no outstanding debt for TENX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TENX Yearly Shares OutstandingTENX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TENX Yearly Total Debt VS Total AssetsTENX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 13.84 indicates that TENX is not in any danger for bankruptcy at the moment.
  • TENX's Altman-Z score of 13.84 is amongst the best of the industry. TENX outperforms 84.50% of its industry peers.
  • There is no outstanding debt for TENX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.84
ROIC/WACCN/A
WACCN/A
TENX Yearly LT Debt VS Equity VS FCFTENX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 14.56 indicates that TENX has no problem at all paying its short term obligations.
  • TENX has a better Current ratio (14.56) than 90.70% of its industry peers.
  • TENX has a Quick Ratio of 14.56. This indicates that TENX is financially healthy and has no problem in meeting its short term obligations.
  • TENX has a Quick ratio of 14.56. This is amongst the best in the industry. TENX outperforms 90.70% of its industry peers.
Industry RankSector Rank
Current Ratio 14.56
Quick Ratio 14.56
TENX Yearly Current Assets VS Current LiabilitesTENX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. TENX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 75.00% over the past year.
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-111.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 21.42% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-19.64%
EPS Next 2Y-5.89%
EPS Next 3Y5.75%
EPS Next 5Y21.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TENX Yearly Revenue VS EstimatesTENX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
TENX Yearly EPS VS EstimatesTENX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5K -10K -15K -20K

More info and screens

Find the best growth stocksShow best growing peers

0

4. TENX Valuation Analysis

4.1 Price/Earnings Ratio

  • TENX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TENX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TENX Price Earnings VS Forward Price EarningsTENX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TENX Per share dataTENX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.89%
EPS Next 3Y5.75%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TENX Dividend Analysis

5.1 Amount

  • TENX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TENX Fundamentals: All Metrics, Ratios and Statistics

TENAX THERAPEUTICS INC

NASDAQ:TENX (4/17/2026, 8:00:00 PM)

After market: 14.45 0 (0%)

14.45

+0.97 (+7.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-10
Earnings (Next)05-12
Inst Owners43.77%
Inst Owner Change0%
Ins Owners0.11%
Ins Owner Change0.26%
Market Cap248.54M
Revenue(TTM)N/A
Net Income(TTM)-52.60M
Analysts86.67
Price Target29.33 (102.98%)
Short Float %1.03%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.63%
Min EPS beat(2)-25.49%
Max EPS beat(2)10.23%
EPS beat(4)1
Avg EPS beat(4)-16.89%
Min EPS beat(4)-41.99%
Max EPS beat(4)10.23%
EPS beat(8)4
Avg EPS beat(8)7.43%
EPS beat(12)7
Avg EPS beat(12)10.61%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.86%
PT rev (3m)13.86%
EPS NQ rev (1m)5.88%
EPS NQ rev (3m)5.88%
EPS NY rev (1m)0.48%
EPS NY rev (3m)0.48%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.56
P/tB 2.56
EV/EBITDA N/A
EPS(TTM)-1.33
EYN/A
EPS(NY)-1.59
Fwd EYN/A
FCF(TTM)-2.08
FCFYN/A
OCF(TTM)-2.08
OCFYN/A
SpS0
BVpS5.64
TBVpS5.64
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -50.47%
ROE -54.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-44.89%
ROA(5y)-201.92%
ROE(3y)-56.18%
ROE(5y)-337.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.56
Quick Ratio 14.56
Altman-Z 13.84
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-111.11%
EPS Next Y-19.64%
EPS Next 2Y-5.89%
EPS Next 3Y5.75%
EPS Next 5Y21.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-189.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-141.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-141.71%
OCF growth 3YN/A
OCF growth 5YN/A

TENAX THERAPEUTICS INC / TENX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TENAX THERAPEUTICS INC (TENX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to TENX.


What is the valuation status of TENAX THERAPEUTICS INC (TENX) stock?

ChartMill assigns a valuation rating of 0 / 10 to TENAX THERAPEUTICS INC (TENX). This can be considered as Overvalued.


How profitable is TENAX THERAPEUTICS INC (TENX) stock?

TENAX THERAPEUTICS INC (TENX) has a profitability rating of 1 / 10.


How financially healthy is TENAX THERAPEUTICS INC?

The financial health rating of TENAX THERAPEUTICS INC (TENX) is 8 / 10.